Literature DB >> 2571799

Disassociation between debrisoquine hydroxylation phenotype and genotype among Chinese.

Q Y Yue, L Bertilsson, M L Dahl-Puustinen, J Säwe, F Sjöqvist, I Johansson, M Ingelman-Sundberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2571799     DOI： 10.1016/s0140-6736(89)93041-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Uses and misuses of definitions of genetic polymorphism. A perspective from population pharmacogenetics.

Authors:  T D Arias; L F Jorge; R Barrantes
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

2.  Genetic analysis of the interethnic difference between Chinese and Caucasians in the polymorphic metabolism of debrisoquine and codeine.

Authors:  I Johansson; Q Y Yue; M L Dahl; M Heim; J Säwe; L Bertilsson; U A Meyer; F Sjöqvist; M Ingelman-Sundberg
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 3.  Fetal drug metabolism and its possible clinical implications.

Authors:  B Krauer; P Dayer
Journal:  Clin Pharmacokinet       Date:  1991-07       Impact factor: 6.447

4.  Distinct phenotypes and genotypes of debrisoquine hydroxylation among Europeans and Chinese.

Authors:  C Mura; J P Broyard; E Jacqz-Aigrain; R Krishnamoorthy
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

5.  Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations.

Authors:  G Alván; P Bechtel; L Iselius; U Gundert-Remy
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

6.  Mutant genes of cytochrome P-450IID6, glutathione S-transferase class Mu, and arylamine N-acetyltransferase in lung cancer patients.

Authors:  I Roots; J Brockmöller; N Drakoulis; R Loddenkemper
Journal:  Clin Investig       Date:  1992 Mar-Apr

7.  Metoprolol oxidation polymorphism in a Korean population: comparison with native Japanese and Chinese populations.

Authors:  D R Sohn; S G Shin; C W Park; M Kusaka; K Chiba; T Ishizaki
Journal:  Br J Clin Pharmacol       Date:  1991-10       Impact factor: 4.335

Review 8.  Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19.

Authors:  L Bertilsson
Journal:  Clin Pharmacokinet       Date:  1995-09       Impact factor: 6.447

9.  A comparison of the pharmacokinetics of codeine and its metabolites in healthy Chinese and Caucasian extensive hydroxylators of debrisoquine.

Authors:  Q Y Yue; J O Svensson; F Sjöqvist; J Säwe
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.